BDBM50263237 (4-(3-chlorophenyl)piperazin-1-yl)(5-(3-methoxyphenyl)-1-p-tolyl-1H-pyrazol-3-yl)methanone::CHEMBL479063
SMILES: COc1cccc(c1)-c1cc(nn1-c1ccc(C)cc1)C(=O)N1CCN(CC1)c1cccc(Cl)c1
InChI Key: InChIKey=UAHNACNOMGLOPA-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cholecystokinin receptor (Homo sapiens (Human)) | BDBM50263237 ((4-(3-chlorophenyl)piperazin-1-yl)(5-(3-methoxyphe...) | PDB Reactome pathway KEGG DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Inhibition of human CCK1 receptor | Bioorg Med Chem Lett 18: 4393-6 (2008) Article DOI: 10.1016/j.bmcl.2008.06.057 BindingDB Entry DOI: 10.7270/Q2HH6JW0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Cholecystokinin receptor (Homo sapiens (Human)) | BDBM50263237 ((4-(3-chlorophenyl)piperazin-1-yl)(5-(3-methoxyphe...) | PDB Reactome pathway KEGG DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | Article PubMed | n/a | n/a | n/a | n/a | 308 | n/a | n/a | n/a | n/a |
Merck Research Laboratories Curated by ChEMBL | Assay Description Agonist activity against human CCK1 receptor | Bioorg Med Chem Lett 18: 4393-6 (2008) Article DOI: 10.1016/j.bmcl.2008.06.057 BindingDB Entry DOI: 10.7270/Q2HH6JW0 | |||||||||||
More data for this Ligand-Target Pair |